IMCC (IM Cannabis) Valuation Rank


IMCC IM Cannabis Corp IMCC
36 GF Score
Price $0.14
GF Value $1.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is IM Cannabis Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

IM Cannabis Valuation Rank Related Terms

IMCC
36GF Score
IM Cannabis Corp IMCC
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IM Cannabis (IMCC) Overvalued in 2026?

Based on GuruFocus' analysis, IM Cannabis stock appears to be undervalued. The current stock price of $0.14 is trading 89.9% below its estimated GF Value™ of $1.39. GuruFocus considers IM Cannabis to be Possible Value Trap.

Key valuation signals for IMCC:

  • Valuation Rank:
  • GF Value™: $1.39 vs. price of $0.14 (89.9% below fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the IMCC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IM Cannabis Business Description

Address Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
36GF Score

Get the complete analysis for IMCC

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$1.39
GF Value